Search results
Results will auto-populate based on filter selection.
Found 986 result(s)
16-01-01
Policy
A worker who has a permanent impairment due to work-related asthma is entitled to a non-economic loss (NEL) benefit, based on the degree of the worker's permanent…
16-01-09
Policy
A worker who has a permanent impairment due to work-related Hand Arm Vibration Syndrome (HAVS) is entitled to a non-economic loss (NEL) benefit, based on the degree…
18-02-02
Policy
Short-term average earnings are the worker’s earnings from the accident employer and all other employment at the time of the injury. Loss of earnings (LOE) benefits…
11-01-04
Policy
A worker’s date of injury varies based on the nature of the event(s) that give rise to his or her claim for benefits under the Workplace Safety and Insurance Act…
18-07-01
Policy
When residual impairment continues even though maximum medical recovery (MMR) expected has been reached following an accident, the WSIB determines the…
18-05-03
Policy
A worker who has a work-related permanent impairment is entitled to a non-economic (NEL) benefit based on the degree of his/her work-related permanent impairment…
You can ensure you receive your WSIB benefit payments quickly and efficiently by using the WSIB’s direct deposit services.Direct deposit is a fast, safe and easy way to…
You can use a third-party representative to provide advice and help you interact with us. Authorized representatives can receive verbal or written information from us about…
Our records We keep records ranging from corporate information to reference material to personal information, which are described below in the Directory…
General records: Internal and External Policy Advice Occupational Disease Scientific Reviews and Opinions Policy Development – Original Approved Policies Policy…
21-02-01
Policy
All claim file information is considered personal information under the Freedom of Information and Protection of Privacy Act (FIPPA) and may be disclosed in…
21-02-02
Policy
The WSIB provides access to claim file information to the workplace parties whenever there is an issue in dispute.
21-02-03
Policy
All claim file information is considered personal information under the Freedom of Information and Protection of Privacy Act (FIPPA) and may be disclosed in…
21-02-05
Policies
All claim file information is considered personal information under The Freedom of Information and Protection of Privacy Act (FIPPA) and may be disclosed…
21-02-04
Policy
All claim file information is considered personal information under The Freedom of Information and Protection of Privacy Act (FIPPA) and may be disclosed in…
21-02-06
Policy
All claim file information is considered personal information under the Freedom of Information and Protection of Privacy Act (FIPPA) and may be disclosed in…
15-04-07
Policy
Where the worker is seriously and permanently disfigured about the face or neck, the WSIB may allow a lump sum in compensation, which is separate and distinct from a…
Update July 26, 2023 The first phase of our consultation began on June 8, 2023 and closed on July 21, 2023. We appreciate all the feedback received, which overwhelmingly…
Each year, we are required under the Workplace Safety and Insurance Act to conduct a value-for-money audit. The latest audit focused on the dispute resolution, appeals and…
12-04-14
Law
s.2(1)
Full-time domestic workers are covered under Schedule 1 of the Act.
Policy
The WSIB provides coverage for domestic workers who are employed more than 24 hours…
On this page: 1. Introduction 1.1. Background 2. Occupational disease legislative and policy scheme…
The Drug Advisory Committee was established in 2007 to guide WSIB on which drugs to include in our drug benefit plan as well as the medical conditions and criteria needed for…
Each year, we are required under the Workplace Safety and Insurance Act (WSIA) to have an external firm review the cost, efficiency, and effectiveness of one of our programs…
Indication(s)The treatment of schizophrenia and related psychotic disorders, manic or mixed episodes in bipolar I disorder, and for use as an adjunct to antidepressants for…
Indication(s)Benzodiazepines are indicated in a treatment of a variety of disorders (depending on their pharmacokinetic profile and evidence), including anxiety disorder,…
Onabotulinumtoxin-A, incobotulinumtoxin-A, abobotulinumtoxin-A Indication(s) OnabotulinumtoxinA (Botox®) is indicated for the treatment of blepharospasm/VII…
Buprenorphine/naloxone (SL), buprenorphine subdermal implant and buprenorphine extended-release (ER) injection Indication(s) Buprenorphine/naloxone sublingual (SL) tablet (…
Burpenorphine transdermal patch - butrans® and burprenorphine buccal soluble film belbuca®Indication(s)The management of pain severe enough to require daily, continuous, long…
Indication Prevention of migraine in adults who have at least four migraine days per month. Formulary Status The WSIB Drug Advisory Committee (DAC) recommended that…
Indication(s)Compounded topical analgesics have not been approved by Health Canada and thus have no official indication for the topical treatment of pain.Formulary statusThe…
Corticosteroid injections in musculoskeletal conditions Indications/Clinical uses Treatment of acute and chronic musculoskeletal conditions including neck and upper…
Indication(s)Symptomatic relief of major depressive disorder (MDD).DAC recommendationThe Drug Advisory Committee (DAC) has recommended that desvenlafaxine not be listed on…
Indication (s)Treatment of symptoms associated with osteoarthritis of the knee (duration of treatment not to exceed 3 months).DAC recommendationThe Drug Advisory Committee (…
Indication(s)Symptomatic relief of major depressive disorder (MDD), generalized anxiety disorder (GAD), neuropathic pain associated with diabetic peripheral neuropathy (DPN…
Indication(s)Treatment of major depressive disorder (MDD), generalized anxiety disorder (GAD), and obsessive compulsive disorder (OCD).Formulary statusThe Drug Advisory…
Indication(s)Clinical management of occupational exposure to HIV.Formulary statusThe Drug Advisory Committee (DAC) recommended antiretroviral medications emtricitabine/…
Hypnotics: zopiclone, zolpidem, trazodone and tryptophanIndication(s)Zopiclone and sublingual zolpidem (oral disintegrating tablet, ODT- sublinox®): GABA agonists for short-…
Indication(s)The management of severe nausea and vomiting associated with cancer chemotherapy.Formulary statusThe Drug Advisory Committee (DAC) recommended that generic…
Indication(s)The relief of moderate to severe pain in adults who require continuous opioid analgesia for several days or more. The naloxone component is indicated for the…
Indication(s)Treatment of schizophrenia.DAC recommendationThe Drug Advisory Committee (DAC) recommended that paliperidone not be listed on any WSIB formularies as there are…
Indication(s)Piroxicam is used to treat pain and a variety of inflammatory conditions.DAC recommendationThe Drug Advisory Committee (DAC) has recommended that piroxicam be…
Indication(s)Treatment of neuropathic pain associated with diabetic peripheral neuropathy, postherpetic neuralgia, spinal cord injury and pain associated with fibromyalgia.…
Indication(s)The management of discomfort ± acute muscle spasm associated with painful musculoskeletal (MSK) conditions (cylcobenzaprine, methocarbamol, and orphenadrine).The…
Indication(s)Nucynta® ER is indicated for the management of pain that is severe enough to require daily, continuous, long-term opioid treatment, opioid-responsive; and for…
Indication(s)Treatment of moderate to moderately severe pain.Formulary statusThe Drug Advisory Committee (DAC) recommended that tramadol be covered for people with workplace…
Indication(s)Management of joint pain in osteoarthritis (OA) of the knee in those who have failed to respond to non-pharmacological treatment and trials of simple analgesics…